IDEXX Laboratories (IDXX) return on equity (ROE)

Return on equity · fiscal 2025
66.0%

IDEXX Laboratories (IDXX) earned a return on equity of 66.0% in fiscal 2025 (the year ended December 31, 2025). That is 10.3 percentage points higher than the 55.7% of fiscal 2024. Figures as of 18 Nov 2026, 02:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
66.0%
Change on fiscal 2024
+10.3 pts
Highest on record
241.0%fiscal 2019
Lowest on record
23.8%fiscal 2009
Fiscal years on record
142008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

IDEXX Laboratories return on equity (ROE), in more detail

Across the 14 fiscal years on record (2008–2025), the highest was 241.0% in fiscal 2019 and the lowest 23.8% in fiscal 2009. The fiscal 2025 figure is higher than in 62% of the 13 earlier fiscal years on record, whose median is 55.7%.

History · 14 fiscal years

Return on equity by fiscal year

IDEXX Laboratories return on equity (ROE), year by year

IDEXX Laboratories (IDXX) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202566.0% 10.3 pts up
202455.7% 1.3 pts down
202356.9% 54.6 pts down
2022111.6% 3.6 pts up
2021107.9% 15.9 pts up
202092.0% 149.0 pts down
2019241.0%—
2014154.8% 118.6 pts up
201336.2% 8.2 pts up
201228.0% 2.0 pts down
201130.0% 5.4 pts up
201024.6% 0.9 pts up
200923.8% 2.8 pts down
200826.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of IDEXX Laboratories and comparable companies
CompanyReturn on equityFiscal year
argenx ARGX17.6%2025
Edwards Lifesciences EW10.4%2025
Becton, Dickinson BDX6.6%2025
IDEXX Laboratories IDXX66.0%2025
Medline MDLN10.8%2025
Humana HUM6.7%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IDXX

IDEXX Laboratories, figure by figure

IDEXX Laboratories (IDXX) overview: price, valuation and scorecardAll health care companies by market value

IDEXX Laboratories return on equity (ROE): questions and answers

What is IDEXX Laboratories's return on equity?

IDEXX Laboratories (IDXX) earned a return on equity of 66.0% in fiscal 2025 (the year ended December 31, 2025). That is 10.3 percentage points higher than the 55.7% of fiscal 2024.

Is IDEXX Laboratories's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 62% of the 13 earlier fiscal years on record, whose median is 55.7%.

What are the highest and lowest return on equity figures on record for IDEXX Laboratories?

Across the 14 fiscal years on record (2008–2025), the highest was 241.0% in fiscal 2019 and the lowest 23.8% in fiscal 2009.

How is IDEXX Laboratories's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IDEXX Laboratories (IDXX) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/IDXX/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.